Type 2 and type 3 Gaucher disease: a morphological and biochemical study.

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Gaucher disease is a lysosomal storage disorder with neuronopathic forms (types 2 and 3).
• Accumulation of glucocerebroside is a hallmark of Gaucher disease.
• Understanding glucocerebroside distribution in the brain is crucial for neuronopathic forms.

Purpose of the Study:

• To quantify glucocerebroside levels in nine distinct brain regions of patients with neuronopathic Gaucher disease (types 2 and 3).
• To compare these levels with control brains.
• To correlate glucocerebroside accumulation with neuropathological findings in type 2 Gaucher disease.

Main Methods:

• Analysis of glucocerebroside levels in nine brain regions (frontal, temporal, occipital cortices, cerebellum, thalamus, corpus striatum, pons, medulla, dentate nuclei).
• Comparison of patient brain samples with control brain samples.
• Neuropathological examination including assessment for Gaucher cells, gliosis, and microglial nodules.

Main Results:

• Greatest glucocerebroside accumulation observed in the occipital cortex, followed by temporal and frontal cortices in Gaucher brains.
• Mild increases in cerebellar cortex, corpus striatum, and thalamus, particularly when expressed as a percentage of total non-hydroxy fatty-acid cerebroside.
• Elevated glucocerebroside in type 2 brainstem structures when expressed as a percentage; neuropathological findings (Gaucher cells, gliosis, nodules) correlated with accumulation in type 2 brains, but not in type 3.

Conclusions:

• Both neuronopathic forms of Gaucher disease show elevated glucocerebroside levels in multiple brain regions.
• Glucocerebroside accumulation in type 2 Gaucher disease correlates positively with observed neuropathological abnormalities.
• Type 3 Gaucher brains show similar glucocerebroside patterns but lack observable neuropathological changes.